header advert
Results 1 - 8 of 8
Results per page:
Orthopaedic Proceedings
Vol. 106-B, Issue SUPP_4 | Pages 2 - 2
8 Feb 2024
Dixon JE Rankin IA Sciberras N Khan LAK Barker SL Cairns DA Kumar K
Full Access

In recent years, use of anatomic stemless total shoulder arthroplasty (AsTSA) has increased. Despite evidence to suggest good mid-term results at 2-year follow-up there is a paucity of evidence for longer term follow-up. This study aimed to investigate outcomes at a minimum of 5 years post-operatively following primary AsTSA. This study is a retrospective case series of all patients who underwent a Mathys Affinis AsTSA from July 2010 (first case) to August 2018 (to allow minimum 5-year follow-up). Clinical outcomes included revision rate, range of motion and patient reported outcomes (Oxford Shoulder Score and Numerical Satisfaction Score). Radiological outcome was assessment of radiolucent lines for Lazarus grading. A total of 105 stemless TSAs were implanted. Five patients underwent revision (4.8%). Seventy-five AsTSA's were included in the final study for analysis of 5-year outcomes. Median follow-up time was 6.1 years. Median age was 69 years old and 81% were female. Oxford shoulder score showed a range of 18 to 48, with a median score of 47. Satisfied or very Satisfied was selected in 94.37%. Median range of motion assessments showed forward elevation 160°, abduction 150°, external rotation 40°, and mode internal rotation was to the lumbar spine. No glenoid lucency was present in 79.7%. There were 9.5% with Lazarus Grade 1 lucency, 5.4% with Lazarus Grade 2, and 5.4% Lazarus Grade 3. No humeral lucency was observed. This cohort study demonstrates promising clinical and radiological outcomes for the Mathys Affinis Stemless TSA at minimum 5 years post-operatively


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXXVII | Pages 279 - 279
1 Sep 2012
Lustig S Barba N Servien E Fary C Demey G Neyret P
Full Access

To our knowledge in medial unicompartmental knee arthroplasty (UKA) no study has specifically assessed the difference in outcome between matched gender groups. Previous unmatched gender studies have indicated more favourable results for women. Method. 2 groups of 40 of either sex was determined sufficient power for significant difference. These consecutively were matched with both the pre-operative clinical and radiological findings. Minimum follow up of 2 years, mean follow-up 5.9 years. Mean age at operation was 71 years. Results. In both groups, the mean IKS knee and function scores improved significantly (p< 0.001) post operatively. There were no significant differences were between the 2 groups. In both groups mean preoperative flexion was 130 degrees and remained unchanged at final follow-up. No significant differences in preoperative and postoperative axial alignment and in the number of radiolucent lines, between groups. With component size used there was a significant difference (p < 0.001) between the 2 groups. However the size of the femoral or tibial implant used was significantly related (p< 0.001) to patient height for both sexes. Radiolucent lines were more frequent on the tibial component, but were considered stable with none progressing. No revisions for component failure. 1 patient in each group developed lateral compartment degenerative change. Male group; one conversion to TKA for undiagnosed pain, three patients underwent reoperation without changing the implant. Female group; no implants were revised, and two patients required a reoperation. Kaplan-Meier 5-year survival rate of 93.46% (84.8; 100) for men and100% for women. The survival rate difference is not significant (p=0.28). Conclusion. These results suggest that there is no difference in outcome between sexes and that gender should not enter into the selection criteria for UKA. It also suggests that height and not gender is important to predict the appropriate UKA components


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXXVII | Pages 344 - 344
1 Sep 2012
Torres A Fairen M Mazon A Asensio A Meroño A Blanco A Ballester J
Full Access

Between July 2000 and December 2002, 263 consecutive patients across 5 surgical centers underwent to a revision surgery of a failed acetabular component in which TM acetabular components were used. There were 150 women and 113 men with a mean age of 69.5 years. The indication for acetabular revision was aseptic loosening in 186 cases (70.7%). Clinical evaluations were performed using the Harris hip score, the WOMAC and UCLA activity scale. Implant and screw position, polyethylene wear, radiolucent lines, gaps, and osteolysis were assessed. Preoperatively, acetabular bone deficiency was categorized using the classification of Paprosky et al. Statistical analysis was performed using nonparametric correlations. Standard life table was constructed, and the survival rate was calculated by means of Kaplan-Meier method. The overall mean follow-up was 73.6 months (range, 60–84 months), and no patient was lost to follow-up. The preoperative HHS rating improved from a mean of 43.6 ± 11.4 before revision, to a mean of 82.1 ± 10.7. None of the patients was re-revised for loosening. The cumulative prosthesis survival was 99.2% at 5 years. There was no correlation found between the various degrees of acetabular bony defect and the magnitude of clinical results (independent of pre-revision Paprosky grade). The use of component augments allowed us to minimize the volume of morsellized allograft used for defect repair. TM acetabular component demonstrates promising midterm results similar to those reported by other authors


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXXVII | Pages 509 - 509
1 Sep 2012
Thomas G Hossain M Monk A Gill H Glyn-Jones S Andrew J Murray D Beard D Epos Group N
Full Access

Introduction. Malalignment of some designs of stem is associated with an increased risk of aseptic loosening and revision. We investigated whether the alignment of the cemented polished, double-taper design adversely affected outcome, in a multicentre prospective study. Methods. A multicentre prospective study of 1189 total hip replacements was undertaken to investigate whether there is an association between surgical outcome and femoral stem alignment. All patients underwent a primary THR with the Exeter femoral stem (Stryker Howmedica Osteonics, Mahwah, NJ) and a variety of acetabular components. The primary outcome measure was the Oxford hip score (OHS) and change in OHS at five years. Secondary outcomes included rate of dislocation and revision. Radiographic evaluation of the femoral component was also undertaken. The long axis of the Exeter femoral component and the long axis of the femoral canal were located, and the angle at the point of intersection measured. The cementing quality was determined as defined by Barrack et al. Radiolucent lines at the cement-stem and cement-bone interface in the five year radiographs were defined using the zones described by Gruen et al. Subsidence was measured as the vertical dimension of the radiolucency craniolateral to the shoulder of the stem in Gruen zone 1 as described by Fowler et al. Cement fractures were recorded. Results. The incidence of varus (>5 ° to the femoral axis), and valgus (>5 °) malignment were 3.7% and 0.8% respectively. Pre-operative demographics and OHS were similar in all groups (p > 0.4). There was no significant difference in OHS or change in OHS between neutral and malaligned groups at 5 years (neutral, mean=40.1, change=23.1; varus, mean=40.1, change=23.7; valgus, mean=42.0, change=26.6; p=0.46 and p=0.45 respectively). There was no significant difference in dislocation rate between the groups (p=0.66). There was also no significant difference in revision rate (p=0.34). There were no statistically significant differences in the incidence of femoral radiolucency, stem subsidence or cement fracture (p > 0.1). Conclusion. This study provides evidence that both varus and valgus implantation does not compromise the short to medium term clinical results of the cemented, polished, double-taper stems. Longer follow-up is required to establish the influence of stem alignment on the incidence of aseptic loosening and revision


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXXVII | Pages 23 - 23
1 Sep 2012
Petroff E Petroff E Audebert S Delobelle JM
Full Access

We evaluated the results of Cementless Surface Replacement Arthroplasty (CSRA) of the shoulder in 67 patients with advanced glenohumeral destruction who have an intact rotator cuff. Between november 2002 and december 2008, 70 CSRA (32 Copeland/ Biomet and 38 SMRR/ Lima) were implanted in 67 patients. A deltopectoral approach was used in 34 cases and an anterosuperior approach in 36 cases. Patients were assessed using Constant score, a patient satisfaction score and a detailed radiographic analysis. The mean follow up was 3.4 years (range 1 to 7.5 years). The mean Constant score improved preoperatively from 17.6 points (range 2–55) to an average postoperative score of 66.1 (range 13–91). The pain score improved from 1.13 points (range 0–6) to 12.3 points (range 3–15). The forward flexion and external rotation improved from 71° (range 20 to 140) and 0° (range −40 to +45) to 143° (range 60 to180) and 34.4° (range −20 to +60) respectively. Complications included: 1 subscapularis detachment, 5 secondary rotator cuff tear, 1sepsis, 3 patients with shoulder stiffness. No shift in implant position was observed. 11 humeral components developed radiolucencies at the prosthesis-bone interface. The radiographic analysis involved a system of dividing the prosthesis/bone interface into 5 zones. The best clinical results were significantly achieved in patients with necrosis compared with osteoarthritis (Constant Score, ant. elevation, ext. Rotation). Using regression analysis we found that changes in the head-shaft angle position of the implant (valgus/varus placement of the CSRA) significantly predicted the age and sex adjusted Constant score. When the inclination angle of the humeral head decreases, the adjusted Constant score increases. In the same model, we also found that the lateral offset of the humerus significantly predicted the adjusted Constant score. When the lateral offset of the humerus decreases, the adjusted Constant score increases. The medialization of the glenoid significantly and negatively predicted the Constant score. Conclusion. CSRA of the shoulder outcomes have been comparable with those of stemmed arthroplasties. Radiolucent lines occur with follow up and most of the time located in the S1 area. Glenoid wear and humeral head lateralization negatively impact the clinical score. Cementless Shoulder resurfacing is a viable alternative to conventional shoulder arthroplasty


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XXXVII | Pages 566 - 566
1 Sep 2012
Lee MC Lee JK Seong SC Lee S Jang J Lee SM Shim SH
Full Access

Summary. Revision TKA using CCK prosthesis showed comparable outcome to PS prosthesis in clinical and radiological results. Introduction. In revision total knee arthroplasty (TKA), the goal should be to obtain good motion, function and most importantly stability. The stability depends on remaining soft tissue and implant design. The more the ligaments retain function, the less the implant constraint is needed to achieve stability. With increased constraint, the transfer of joint reaction forces to implant-bone interface may lead to mechanical loosening of the implant. Constrained condylar knee (CCK) prosthesis provides more constraint compared with posterior stabilized (PS) prosthesis. The purpose of this study was to compare the clinical, radiological outcome and survivorship of CCK and PS prosthesis in revision TKA. Materials and Methods. One hundred and twenty-one consecutive revision TKAs using CCK (79 knees) and PS (42 knees) were included. The mean follow-up period was 63.2 months for CCK and 64.8 months for PS. The mean age was 69.5 years and 70.6 years in CCK and PS, respectively. Range of motion (ROM), American Knee Society (AKS) score, Hospital for Special Surgery (HSS) score, complications and failure rate were assessed. Radiographic measurements included tibiofemoral angle and radiolucent lines. The Kaplan-Meier survivorship analysis was performed with an end point of re-revision surgery for any reason and compared between CCK and PS using the Log-rank test. Results. The mean range of motion improved from 97.5° to 115.9° in PS, from 89.5° to 110.1° in CCK. The mean Knee Society knee and functional scores improved from 47.6 and 36.4 to 89.7 and 66.1 with PS, from 53.5 and 41.7 to 79.2 and 66.8 with CCK. The mean Hospital for Special Surgery knee score also improved from 57 to 76.9 and 59.7 to 77.6, respectively. The complication rate was 7.5% (4 cases; 3 recurred infections, 1 instability) in PS and 10.3% (7 cases; 4 recurred infections, 1 periprosthetic fracture, 2 stem tip pains) in CCK. The Kaplan–Meier survivorship analysis revealed that ten year survival of the components was 85.4% for PS and 80.0% for CCK. In all aspects, there were no statistical difference (a p-value of more than 0.05) between PS and CCK. Conclusion. Revision TKA using CCK prosthesis showed comparable outcome to PS prosthesis in clinical and radiological results. CCK prosthesis is a reliable and successful option for prosthesis selection in revision TKA when PS prosthesis is not enough for management of instability


The Bone & Joint Journal
Vol. 99-B, Issue 10 | Pages 1399 - 1408
1 Oct 2017
Scott CEH MacDonald D Moran M White TO Patton JT Keating JF

Aims

To evaluate the outcomes of cemented total hip arthroplasty (THA) following a fracture of the acetabulum, with evaluation of risk factors and comparison with a patient group with no history of fracture.

Patients and Methods

Between 1992 and 2016, 49 patients (33 male) with mean age of 57 years (25 to 87) underwent cemented THA at a mean of 6.5 years (0.1 to 25) following acetabular fracture. A total of 38 had undergone surgical fixation and 11 had been treated non-operatively; 13 patients died at a mean of 10.2 years after THA (0.6 to 19). Patients were assessed pre-operatively, at one year and at final follow-up (mean 9.1 years, 0.5 to 23) using the Oxford Hip Score (OHS). Implant survivorship was assessed. An age and gender-matched cohort of THAs performed for non-traumatic osteoarthritis (OA) or avascular necrosis (AVN) (n = 98) were used to compare complications and patient-reported outcome measures (PROMs).


The Bone & Joint Journal
Vol. 95-B, Issue 5 | Pages 583 - 597
1 May 2013
Kurien T Pearson RG Scammell BE

We reviewed 59 bone graft substitutes marketed by 17 companies currently available for implantation in the United Kingdom, with the aim of assessing the peer-reviewed literature to facilitate informed decision-making regarding their use in clinical practice. After critical analysis of the literature, only 22 products (37%) had any clinical data. Norian SRS (Synthes), Vitoss (Orthovita), Cortoss (Orthovita) and Alpha-BSM (Etex) had Level I evidence. We question the need for so many different products, especially with limited published clinical evidence for their efficacy, and conclude that there is a considerable need for further prospective randomised trials to facilitate informed decision-making with regard to the use of current and future bone graft substitutes in clinical practice.

Cite this article: Bone Joint J 2013;95-B:583–97.